Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2251

1.

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.

Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, Subbiah P; Donepezil MSAD Study Investigators Group.

J Am Geriatr Soc. 2003 Jun;51(6):737-44. Erratum in: J Am Geriatr Soc. 2003 Sep;51(9):1331.

PMID:
12757558
[PubMed - indexed for MEDLINE]
2.

Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.

Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P; Donepezil MSAD Study Investigators' Group.

Curr Med Res Opin. 2002;18(6):347-54.

PMID:
12442882
[PubMed - indexed for MEDLINE]
3.

Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.

Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R; 322 Study Group.

Drugs Aging. 2004;21(1):43-53.

PMID:
14715043
[PubMed - indexed for MEDLINE]
4.

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E; Donepezil MSAD Study Investigators Group.

Neurology. 2001 Aug 28;57(4):613-20. Erratum in: Neurology 2001 Dec 11;57(11):2153.

PMID:
11524468
[PubMed - indexed for MEDLINE]
5.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
[PubMed - indexed for MEDLINE]
6.

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, Whalen E, Emir B; Donepezil MSAD Study Investigators Group.

Int Psychogeriatr. 2002 Dec;14(4):389-404.

PMID:
12670060
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.

Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69.

PMID:
15920715
[PubMed - indexed for MEDLINE]
8.

Economic evaluation of donepezil in moderate to severe Alzheimer disease.

Feldman H, Gauthier S, Hecker J, Vellas B, Hux M, Xu Y, Schwam EM, Shah S, Mastey V; Donepezil MSAD Study Investigators Group.

Neurology. 2004 Aug 24;63(4):644-50.

PMID:
15326236
[PubMed - indexed for MEDLINE]
9.

Impact of donepezil treatment for Alzheimer's disease on caregiver time.

Wimo A, Winblad B, Shah SN, Chin W, Zhang R, McRae T.

Curr Med Res Opin. 2004 Aug;20(8):1221-5.

PMID:
15324524
[PubMed - indexed for MEDLINE]
10.

Donepezil preserves cognition and global function in patients with severe Alzheimer disease.

Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.

Neurology. 2007 Jul 31;69(5):459-69.

PMID:
17664405
[PubMed - indexed for MEDLINE]
11.

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I; Memantine Study Group.

JAMA. 2004 Jan 21;291(3):317-24.

PMID:
14734594
[PubMed - indexed for MEDLINE]
12.

Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.

Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R; AWARE Study Group.

CNS Drugs. 2006;20(4):311-25. Erratum in: CNS Drugs. 2006;20(10):866.

PMID:
16599649
[PubMed - indexed for MEDLINE]
13.

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

Winblad B, Kilander L, Eriksson S, Minthon L, Båtsman S, Wetterholm AL, Jansson-Blixt C, Haglund A; Severe Alzheimer's Disease Study Group.

Lancet. 2006 Apr 1;367(9516):1057-65. Erratum in: Lancet. 2006 Jun 17;367(9527):1980. Lancet. 2006 Nov 11;368(9548):1650.

PMID:
16581404
[PubMed - indexed for MEDLINE]
14.

Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.

Touchon J, Bergman H, Bullock R, Rapatz G, Nagel J, Lane R.

Curr Med Res Opin. 2006 Jan;22(1):49-59. Erratum in: Curr Med Res Opin. 2006 Aug;22(8):1451.

PMID:
16393430
[PubMed - indexed for MEDLINE]
15.

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

Rogers SL, Doody RS, Mohs RC, Friedhoff LT.

Arch Intern Med. 1998 May 11;158(9):1021-31.

PMID:
9588436
[PubMed - indexed for MEDLINE]
16.

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.

Jones RW, Soininen H, Hager K, Aarsland D, Passmore P, Murthy A, Zhang R, Bahra R.

Int J Geriatr Psychiatry. 2004 Jan;19(1):58-67.

PMID:
14716700
[PubMed - indexed for MEDLINE]
17.

Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.

Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R; Donepezil 307 Vascular Dementia Study Group.

Stroke. 2003 Oct;34(10):2323-30. Epub 2003 Sep 11.

PMID:
12970516
[PubMed - indexed for MEDLINE]
Free Article
18.

Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.

Hashimoto M, Yatabe Y, Kaneda K, Honda K, Ikeda M.

Psychogeriatrics. 2009 Dec;9(4):196-203. doi: 10.1111/j.1479-8301.2009.00302.x.

PMID:
20377821
[PubMed - indexed for MEDLINE]
19.

Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.

Jelic V, Haglund A, Kowalski J, Langworth S, Winblad B.

Dement Geriatr Cogn Disord. 2008;26(5):458-66. doi: 10.1159/000167267. Epub 2008 Nov 4.

PMID:
18984956
[PubMed - indexed for MEDLINE]
20.

Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.

Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R.

Curr Med Res Opin. 2006 Mar;22(3):483-94.

PMID:
16574032
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk